Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.100 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.44 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used